GSS
GENETICSIG FPO [GSS]
Healthcare · ASX Small Cap
$0.0870 -3.3%
Updated 3 Sep 2026 · Signals refresh every scan
Appeared in 3 consecutive scansFirst seen: 2026-02-26
Get alerts when GSS triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Trading above both moving averages — the trend is your friend here
- Volume surging at 2.7x normal while price falls — heavy selling pressure
- Beating the Small Ords index — relative strength of 1.53, so it's outpacing the pack
- Volatility is expanding fast — choppy price action, so buckle up
- Strong cash runway (11 quarters)
- Low P/S ratio (1.0x)
- EPS estimates revised upward (+10pts)
- Near 52-week low (9% of range)
- Micro-cap ($5-20M) - high risk
- Substantial holder(s) ceased (1)
- CANSLIM I: Institutional ownership (41%)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 80% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (1.61%/day)
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Revenue declining (-5%)
- Piotroski F-Score weak (3/9, low-confidence approx)
- Deeply negative margins (-72%)
- Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about GSS
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE BDX Holdings of GSS Shares and receipt of Section 249D
NONE Final Director's Interest Notice
LOW Board Changes
HIGH Ceasing to be a substantial holder
HIGH Genetic Signatures and Microba in Merger Discussions
Announcement tone +3pts
Recent ASX Announcements
| 2026-09-02 | BDX Holdings of GSS Shares and receipt of Section 249D PRICE SENSITIVE |
| 2026-09-01 | Final Director's Interest Notice |
| 2026-08-30 | Board Changes |
| 2026-08-27 | Ceasing to be a substantial holder |
| 2026-08-25 | Genetic Signatures and Microba in Merger Discussions PRICE SENSITIVE |
Key Metrics
$19.3M
Market Cap
552K
Avg Volume
2.7x
Vol Ratio
$0.05 — $0.43
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-32.6%
ROE
-72.5%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 67% |
| L | Leader vs Laggard | pass | RS: 9 |
| I | Institutional Sponsorship | pass | Inst: 41% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
113 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track GSS and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required